SCHEMBL7881978

SCHEMBL7881978

CN(C(=N)N)C(=O)c1cc2ccc(Oc3ccnc(CN4CCCC4)c3)cc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.40
KMT2A Q03164 2/20 0.38
RXFP1 Q9HBX9 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SYK P43405 4/20 0.37
SLC6A4 P31645 1/20 0.36
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
PDGFRB P09619 1/20 0.35
PDGFRA P16234 1/20 0.35
HRH4 Q9H3N8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884349 0.87 KMT2A (0.43) FLT3KMT2ARXFP1MEN1NPC1
SCHEMBL7881919 0.87 KDR (0.34) SLC6A4DRD2DRD3
SCHEMBL7880873 0.87 RXFP1 (0.43) FLT3KMT2ARXFP1MEN1NPC1
SCHEMBL7882017 0.86 FLT3 (0.39) FLT3KMT2ARXFP1MEN1NPC1
SCHEMBL7879877 0.86 FLT3 (0.42) FLT3KMT2ARXFP1MEN1NPC1
SCHEMBL7882090 0.85 SCN9A (0.37) SLC6A4
SCHEMBL7881140 0.84 RXFP1 (0.45) FLT3KMT2ARXFP1MEN1KDM4E
SCHEMBL7879616 0.84 SLC6A4 (0.39) SLC6A4DRD2DRD3HRH4
SCHEMBL7881119 0.84 ROCK2 (0.39) FLT3KMT2ARXFP1MEN1NPC1
SCHEMBL7881076 0.83 RXFP1 (0.44) FLT3KMT2ARXFP1MEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed